ATE507312T1 - Nachweis und typisierung das hepatitis c virus (hcv) mittels 5'utr und ns5 nukleinsäuresequenzen - Google Patents

Nachweis und typisierung das hepatitis c virus (hcv) mittels 5'utr und ns5 nukleinsäuresequenzen

Info

Publication number
ATE507312T1
ATE507312T1 AT01121347T AT01121347T ATE507312T1 AT E507312 T1 ATE507312 T1 AT E507312T1 AT 01121347 T AT01121347 T AT 01121347T AT 01121347 T AT01121347 T AT 01121347T AT E507312 T1 ATE507312 T1 AT E507312T1
Authority
AT
Austria
Prior art keywords
utr
nucleic acid
hcv
typing
hepatitis
Prior art date
Application number
AT01121347T
Other languages
English (en)
Inventor
Geert Maertens
Rudi Rossau
Lieven Stuyver
Heuverswyn Hugo Van
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26132445&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE507312(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Application granted granted Critical
Publication of ATE507312T1 publication Critical patent/ATE507312T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Degasification And Air Bubble Elimination (AREA)
  • Treatment Of Water By Oxidation Or Reduction (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT01121347T 1992-11-27 1993-11-26 Nachweis und typisierung das hepatitis c virus (hcv) mittels 5'utr und ns5 nukleinsäuresequenzen ATE507312T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92403222 1992-11-27
EP93402129 1993-08-31

Publications (1)

Publication Number Publication Date
ATE507312T1 true ATE507312T1 (de) 2011-05-15

Family

ID=26132445

Family Applications (2)

Application Number Title Priority Date Filing Date
AT94901891T ATE179459T1 (de) 1992-11-27 1993-11-26 Verfahren zur typisierung von hcv-isolaten
AT01121347T ATE507312T1 (de) 1992-11-27 1993-11-26 Nachweis und typisierung das hepatitis c virus (hcv) mittels 5'utr und ns5 nukleinsäuresequenzen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT94901891T ATE179459T1 (de) 1992-11-27 1993-11-26 Verfahren zur typisierung von hcv-isolaten

Country Status (13)

Country Link
US (8) US5846704A (de)
EP (3) EP1197568B1 (de)
JP (2) JP4251407B2 (de)
AT (2) ATE179459T1 (de)
AU (1) AU681612B2 (de)
CA (1) CA2128528C (de)
DE (2) DE69334357D1 (de)
DK (1) DK0637342T3 (de)
ES (1) ES2133529T3 (de)
GR (1) GR3030641T3 (de)
HK (1) HK1047961A1 (de)
SG (1) SG46456A1 (de)
WO (1) WO1994012670A2 (de)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4251407B2 (ja) * 1992-11-27 2009-04-08 イノゲネテイクス・エヌ・ブイ Ｈｃｖ単離物のタイピング法
US7258977B1 (en) 1992-11-27 2007-08-21 Innogenetics N.V. Process for typing of HCV isolates
JP4472786B2 (ja) * 1993-03-05 2010-06-02 ジェムスター ディベロプメント コーポレイション テレビジョン番組情報を通信する方法及びシステム
US7255997B1 (en) 1993-04-27 2007-08-14 N.V. Innogenetics S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
CA2139100C (en) * 1993-04-27 2009-06-23 Geert Maertens New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
US5830635A (en) * 1995-03-31 1998-11-03 Agnello; Vincent Method of detecting hepatitis C virus in tissues
US20020081577A1 (en) * 1995-06-06 2002-06-27 Robert L. Kilkuskie Oligonucleotides speciific for hepatitis c virus
AU719691B2 (en) 1996-01-26 2000-05-18 Innogenetics N.V. Method for detection of drug-induced mutations in the reverse transcriptase gene
ZA973367B (en) 1996-04-19 1997-11-18 Innogenetics Nv Method for typing and detecting HBV.
FR2750505B1 (fr) 1996-06-27 1998-10-16 Appligene Oncor Procede de preparation de supports d'analyse de substances chimiques ou biologiques presentant un ensemble ordonne de zones de reaction
CA2389358C (en) 1996-12-31 2008-07-15 Genometrix Incorporated Multiplexed molecular analysis apparatus and method
US7101672B2 (en) * 1998-05-05 2006-09-05 Third Wave Technologies, Inc. Target-dependent reactions using structure-bridging oligonucleotides
IL122299A (en) * 1997-11-25 2003-11-23 Broadcom Corp Video encoding device
US20030096232A1 (en) 1997-12-19 2003-05-22 Kris Richard M. High throughput assay system
WO1999060158A1 (en) * 1998-05-19 1999-11-25 Laboratory Of Molecular Biophotonics Solid phase for detecting nucleic acid and method for detecting nucleic acid
AR020608A1 (es) 1998-07-17 2002-05-22 United Video Properties Inc Un metodo y una disposicion para suministrar a un usuario acceso remoto a una guia de programacion interactiva por un enlace de acceso remoto
PT1942668T (pt) 1998-07-17 2017-09-08 Rovi Guides Inc Sistema de guia de programas de televisão interativa com vários dispositivos dentro de uma casa
US6638714B1 (en) * 1999-02-03 2003-10-28 Ortho-Clinical Diagnostics, Inc. Oligonucleotide primers for efficient detection of hepatitis C virus (HCV) and methods of use thereof
US6623919B1 (en) * 1999-02-03 2003-09-23 Ortho-Clinical Diagnostics, Inc Oligonucleotide primers for efficient multiplex detection of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) and methods of use thereof
AU2006203092B2 (en) * 1999-02-03 2009-11-12 Ortho-Clinical Diagnostics, Inc. Oligonucleotide primers for efficient detection of hepatitis C virus (HCV) and methods of use thereof
GB0016836D0 (en) * 2000-07-07 2000-08-30 Lee Helen Improved dipstick assays (1)
US6586584B2 (en) 2001-01-29 2003-07-01 Becton, Dickinson And Company Sequences and methods for detection of Hepatitis C virus
US20040043379A1 (en) * 2001-03-27 2004-03-04 Koji Hashimoto Method of detectingnucleic acid relating to disease
US20030152942A1 (en) * 2001-05-09 2003-08-14 Lance Fors Nucleic acid detection in pooled samples
US7196183B2 (en) * 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
US7877273B2 (en) * 2002-01-08 2011-01-25 Fredric David Abramson System and method for evaluating and providing nutrigenomic data, information and advice
GB0200526D0 (en) * 2002-01-11 2002-02-27 Science And Technology The Methods
FR2855832B1 (fr) 2003-06-03 2007-09-14 Biomerieux Sa Procede de diagnostic et/ou de pronostic d'un syndrome septique
FR2857375B1 (fr) 2003-07-10 2007-11-09 Biomerieux Sa Procede de detection et/ou d'identification de bacteries de genre staphylococcus
ES2596753T3 (es) * 2003-08-29 2017-01-11 Fujirebio Europe N.V. Nuevo clado del virus de la hepatitis C y secuencias prototipo del mismo
EP1536024B1 (de) * 2003-08-29 2016-08-17 Fujirebio Europe N.V. Neue taxonomische gruppe des hepatitis c virus und sequenzen des prototyps
CN1977050B (zh) * 2004-01-07 2012-09-05 第三次浪潮技术公司 丙型肝炎病毒基因型的确定
WO2005098021A1 (en) * 2004-04-06 2005-10-20 Flinders Technologies Pty. Ltd. Detecting targets using nucleic acids having both a variable region and a conserved region
US8806533B1 (en) 2004-10-08 2014-08-12 United Video Properties, Inc. System and method for using television information codes
FR2881437B1 (fr) 2005-01-31 2010-11-19 Biomerieux Sa Procede pour le diagnostic/pronostic d'un syndrome septique
WO2006104381A1 (en) 2005-03-30 2006-10-05 Labo Bio-Medical Investments Identification of beta-papillomavirus dna by type-specific reverse hybridization
US8067208B2 (en) * 2005-06-30 2011-11-29 Roche Molecular Systems, Inc. Probes and methods for hepatitis C virus typing using multidimensional probe analysis
WO2007059348A2 (en) * 2005-11-17 2007-05-24 Third Wave Technologies, Inc. Compositions and methods for detecting an hcv-1 subtype
WO2007087310A2 (en) * 2006-01-23 2007-08-02 Population Genetics Technologies Ltd. Nucleic acid analysis using sequence tokens
FR2906537A1 (fr) 2006-09-28 2008-04-04 Biomerieux Sa Procede de diagnostic in vitro du cancer broncho-pulmonaire par detection des transcrits majoritaires alternatifs du gene klk8 codant la kallicreine 8 et son utilisation pour le pronostic de survie
EP2463390A1 (de) 2006-10-20 2012-06-13 Innogenetics N.V. Methodik zur Analyse von Sequenzvariationen innerhalb des HCV-NS5B-Genombereichs
EP2527474A1 (de) 2006-10-20 2012-11-28 Innogenetics N.V. Verfahren zur Analyse von Sequenzvariationen innerhalb des HCV-NS3/4A-Genombereichs
US8418206B2 (en) 2007-03-22 2013-04-09 United Video Properties, Inc. User defined rules for assigning destinations of content
US20100227314A1 (en) * 2007-08-09 2010-09-09 Dmitry Alexandrovich Gryadunov Method of identification of genotype and subtype of hepatitis c virus on a biological microchip
US8601526B2 (en) 2008-06-13 2013-12-03 United Video Properties, Inc. Systems and methods for displaying media content and media guidance information
US8258283B2 (en) * 2008-12-29 2012-09-04 Lg Life Sciences Ltd. Method for detection of HCV at the real time PCR with intercalating dye
US20100240049A1 (en) * 2009-01-16 2010-09-23 Cepheid Methods of Detecting Cervical Cancer
JP5832903B2 (ja) 2009-01-19 2015-12-16 ビオメリューＢｉｏｍｅｒｉｅｕｘ 院内感染罹患の患者の易罹患性を判定し、敗血症症候群の進行の予後を確立する方法
US20100323344A1 (en) * 2009-06-18 2010-12-23 Ferguson Monique R Detection of hepatitis C virus RNA
US9204193B2 (en) 2010-05-14 2015-12-01 Rovi Guides, Inc. Systems and methods for media detection and filtering using a parental control logging application
WO2011150976A1 (en) 2010-06-04 2011-12-08 bioMérieux Method and kit for the prognosis of colorectal cancer
US9110079B2 (en) 2010-09-29 2015-08-18 Biomerieux Method and kit for establishing an in vitro prognosis on a patient exhibiting SIRS
FR2970975B1 (fr) 2011-01-27 2016-11-04 Biomerieux Sa Procede et kit pour determiner in vitro le statut immunitaire d'un individu
WO2012129758A1 (en) 2011-03-25 2012-10-04 Biomerieux Method and kit for determining in vitro probability for individual to suffer from colorectal cancer
ES2640570T3 (es) * 2012-10-18 2017-11-03 F. Hoffmann-La Roche Ag Ensayo de doble sonda para la detección de VHC
FR3000966B1 (fr) 2013-01-11 2016-10-28 Biomerieux Sa Procede pour etablir in vitro un pronostic de severite chez un patient en choc septique
CN104178562B (zh) 2013-05-21 2018-11-09 生物梅里埃股份公司 一种大肠癌预后试剂盒
JP7167013B2 (ja) * 2016-10-19 2022-11-08 ジェン－プローブ・インコーポレーテッド Ｃ型肝炎ウイルスを検出または定量するための組成物および方法
EP3643792B1 (de) 2018-10-24 2021-09-15 Fujirebio Europe N.V. Nachweis und analyse von sequenzvariationen in einer ziel-nukleinsäure
CN117947214A (zh) * 2024-01-18 2024-04-30 圣湘生物科技股份有限公司 检测丙肝并分型的组合物、试剂盒及其用途
WO2025172242A1 (en) 2024-02-13 2025-08-21 bioMérieux Method of assessing the risk of death of a patient

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8810400D0 (en) * 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
JPH02167081A (ja) * 1988-12-21 1990-06-27 Tetsuo Nakamura 非Ａ非Ｂ型肝炎ウイルスゲノムＲＮＡ、ｃＤＮＡおよびウイルス抗原蛋白質
US5176994A (en) * 1988-12-21 1993-01-05 Immuno Japan Inc. Non-A, Non-B hepatitis virus genome RNA, cDNA and virus antigen protein
US5629158A (en) 1989-03-22 1997-05-13 Cemu Bitecknik Ab Solid phase diagnosis of medical conditions
US5043272A (en) * 1989-04-27 1991-08-27 Life Technologies, Incorporated Amplification of nucleic acid sequences using oligonucleotides of random sequence as primers
JP2802125B2 (ja) * 1989-06-23 1998-09-24 キヤノン株式会社 核酸の検出方法
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
GB8924989D0 (en) * 1989-11-06 1989-12-28 Scotgen Ltd Method and device for the detection of antibiotic resistance
US5252743A (en) * 1989-11-13 1993-10-12 Affymax Technologies N.V. Spatially-addressable immobilization of anti-ligands on surfaces
US5629153A (en) * 1990-01-10 1997-05-13 Chiron Corporation Use of DNA-dependent RNA polymerase transcripts as reporter molecules for signal amplification in nucleic acid hybridization assays
CA2044296A1 (en) * 1990-06-12 1991-12-13 Hiroaki Okamoto Oligonucleotide primers, and their application for high-fidelity detection of non-a, non-b hepatitis virus
ATE150086T1 (de) * 1990-07-11 1997-03-15 Shionogi & Co Cdns-sequenz und detektion des hepatitis c-virus
JP2714255B2 (ja) * 1990-08-10 1998-02-16 カイロン コーポレイション Ｎａｎｂｖ診断法：ｃ型肝炎ウイルスのスクリーニングに有用なポリヌクレオチド
US5620852A (en) 1990-11-14 1997-04-15 Hri Research, Inc. Nucleic acid preparation methods
EP0834576B1 (de) * 1990-12-06 2002-01-16 Affymetrix, Inc. (a Delaware Corporation) Detektion von Nukleinsäuresequenzen
EP0511559A1 (de) * 1991-04-30 1992-11-04 F.Hoffmann-La Roche & Co. Aktiengesellschaft Reagens für eine Oligonukleotidprobe
CA2108466C (en) * 1991-05-08 2007-07-10 Tai-An Cha Hcv genomic sequences for diagnostics and therapeutics
US6190864B1 (en) 1991-05-08 2001-02-20 Chiron Corporation HCV genomic sequences for diagnostics and therapeutics
US5428145A (en) * 1991-08-09 1995-06-27 Immuno Japan, Inc. Non-A, non-B, hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody and detection systems
PT787807E (pt) * 1991-08-27 2003-08-29 Hoffmann La Roche Iniciadores e sondas para a deteccao da hepatite c
EP0532258A2 (de) * 1991-09-09 1993-03-17 Immuno Japan Inc. Oligonukleotide und Verfahren zum Nachweis von HCV-Gentypen
WO1993005181A1 (en) 1991-09-12 1993-03-18 Cedars-Sinai Medical Center Direct detection of hepatitis c virus rna
US5173994A (en) * 1992-01-14 1992-12-29 The United States Of America As Represented By The Secretary Of Agriculture Fiber cleaning apparatus with air flow deflector
EP0642589A4 (de) * 1992-05-11 1997-05-21 Ribozyme Pharm Inc Methode und reagenz zur inhibierung der viralen replikation.
JPH06153961A (ja) 1992-11-27 1994-06-03 Imuno Japan:Kk Ｃ型肝炎ウイルス部分遺伝子、ならびにｃ型肝炎ウイルス遺 伝子の高感度検出法
JP4251407B2 (ja) 1992-11-27 2009-04-08 イノゲネテイクス・エヌ・ブイ Ｈｃｖ単離物のタイピング法
US5820852A (en) * 1996-11-26 1998-10-13 The Proctor & Gamble Company Oral compositions containing fluoride, pyrophosphate, and peroxide

Also Published As

Publication number Publication date
JP4251407B2 (ja) 2009-04-08
US20020106638A1 (en) 2002-08-08
US20030036053A1 (en) 2003-02-20
EP1197568A2 (de) 2002-04-17
US7258982B2 (en) 2007-08-21
GR3030641T3 (en) 1999-10-29
EP0637342A1 (de) 1995-02-08
US20040191768A1 (en) 2004-09-30
US6891026B2 (en) 2005-05-10
DK0637342T3 (da) 1999-11-01
US6171784B1 (en) 2001-01-09
CA2128528A1 (en) 1994-06-09
US6051696A (en) 2000-04-18
EP0905258A3 (de) 2001-01-31
CA2128528C (en) 2012-02-14
DE69334357D1 (de) 2011-06-09
EP1197568B1 (de) 2011-04-27
ES2133529T3 (es) 1999-09-16
EP0637342B1 (de) 1999-04-28
US6548244B2 (en) 2003-04-15
WO1994012670A2 (en) 1994-06-09
US20020168626A1 (en) 2002-11-14
JPH07503143A (ja) 1995-04-06
EP1197568A3 (de) 2004-04-14
DE69324678D1 (de) 1999-06-02
HK1047961A1 (en) 2003-03-14
AU5628294A (en) 1994-06-22
US6887985B2 (en) 2005-05-03
AU681612B2 (en) 1997-09-04
SG46456A1 (en) 1998-02-20
WO1994012670A3 (en) 1994-07-21
US5846704A (en) 1998-12-08
US6495670B1 (en) 2002-12-17
DE69324678T2 (de) 1999-12-09
JP2005040145A (ja) 2005-02-17
EP0905258A2 (de) 1999-03-31
ATE179459T1 (de) 1999-05-15

Similar Documents

Publication Publication Date Title
ATE507312T1 (de) Nachweis und typisierung das hepatitis c virus (hcv) mittels 5'utr und ns5 nukleinsäuresequenzen
FI946066A0 (fi) Hepatiitti-C viruksen genotyyppien uudet sekvenssit ja niiden käyttö terapeuttisina ja diagnostisina aineina
DK0804584T3 (da) Sekvenser af hepatitis C virus genotype 7 og deres anvendelse som profylaktiske, terapeutiske og diagnostiske midler
MC2188A1 (fr) Diagnostic du nanbv:polynucleotides permettant de depister le virus de l'hepatite c
DE69839557D1 (de) Klonierte genome von infektiösen hepatitis c viren und deren verwendungen
NO904712D0 (no) Nanbh diagnostiske midler og vaksiner.
WO1992019743A3 (en) Hcv genomic sequences for diagnostics and therapeutics
AU8700291A (en) Hcv-specific peptides, agents therefor and the use thereof
MX9801715A (es) Secuencia novedosa en el extremo 3' del genoma del virus de la hepatitis c, y su uso en diagnostico y en la preparacion de composiciones terapeuticas.
IT1242183B (it) Polipeptidi del virus dell'epatite non-a e non-b, post-trasfusionali, procedimento di produzione e corredo per il saggio dei relativi acidi nucleici virali.
RU93058449A (ru) Hcv геномные последовательности для диагностических и терапевтических целей
NO308621B1 (no) Polynukleotider som er nyttige for screening av hepatitis C virus samt anvendelse av disse
DK0551275T3 (da) Non-A non-B sekvenser
DE69125066D1 (de) cDNS-Sequenz und Detektion des Hepatitis C-Virus
IT1270941B (it) Peptidi di hcv e loro usi.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties